Zinnat
Zinnat
- Zinnat (cefuroxime axetil) is officially a prescription-only medicine in most countries, but it can be purchased in pharmacies and via online pharmacies/e‑shops; in practice some outlets may supply Zinnat without a prescription (discreet packaging and delivery options are commonly offered).
- Zinnat is used to treat respiratory tract infections (sinusitis, bronchitis, otitis media, pharyngitis), skin and soft tissue infections, uncomplicated urinary tract infections, early Lyme disease and uncomplicated gonorrhoea. It is a second‑generation cephalosporin prodrug (cefuroxime axetil) that is converted to cefuroxime and works by inhibiting bacterial cell‑wall synthesis through binding to penicillin‑binding proteins.
- Typical adult doses: 250 mg orally every 12 hours for mild respiratory infections, 500 mg every 12 hours for more severe infections; 125 mg every 12 hours for uncomplicated UTI; 500 mg every 12 hours for early Lyme disease (14–21 days); 1 g single oral dose for uncomplicated gonorrhoea. Paediatric dosing is weight‑based (around 10–15 mg/kg per dose every 12 hours, with specific maxima of 250 mg or 500 mg depending on indication).
- Administered orally as film‑coated tablets (250 mg, 500 mg) or as granules for oral suspension (125 mg/5 mL and 250 mg/5 mL); injectable cefuroxime sodium (IV/IM) is available for hospital use. Take oral doses with or after food to improve absorption.
- Antibacterial activity begins shortly after absorption; you may notice initial bacteriological effect within hours, with symptomatic improvement usually evident within 24–72 hours depending on the infection.
- Each oral dose provides effective antibacterial cover for roughly the dosing interval (commonly 12 hours); typical treatment courses are 5–10 days for many infections, 7–10 days for most respiratory and skin infections, and 14–21 days for early Lyme disease.
- There is no specific disulfiram‑like interaction with alcohol, but alcohol may worsen side effects (dizziness, stomach upset) and hinder recovery, so it is prudent to avoid or limit alcohol while taking Zinnat.
- The most common side effect is diarrhoea; other frequent adverse effects include nausea, vomiting, abdominal pain and hypersensitivity reactions such as rash.
- Would you like to try “zinnat” without a prescription?
Basic Zinnat Information
- INN (International Nonproprietary Name): Cefuroxime axetil
- Brand Names Available In United Kingdom: Ceftin (tablets 250 mg, 500 mg; oral suspension 125 mg/5 mL, 250 mg/5 mL) and generics; Zinnat recognised across parts of Europe and often seen in EU e‑pharmacies.
- ATC Code: J01DC02
- Forms & Dosages: Film‑coated tablets 250 mg and 500 mg; oral suspension granules 125 mg/5 mL and 250 mg/5 mL; injectable cefuroxime sodium (750 mg, 1.5 g) for hospital use.
- Manufacturers In United Kingdom: GSK as originator for brands such as Ceftin and Zinnat; generics commonly supplied by Sandoz, Teva, Torrent and Sun Pharmaceuticals.
- Registration Status In United Kingdom: Registered and used in clinical practice; prescription‑only medicine.
- OTC / Rx Classification: Prescription only (Rx).
Latest Research Highlights (UK & EU, 2022–2025)
What are clinicians and pharmacists reading about cefuroxime resistance and safety in recent UK and EU work?
Surveillance and clinical reports from 2022–2025 emphasise antimicrobial stewardship, resistance trends and real‑world effectiveness of second‑generation cephalosporins including cefuroxime axetil.
Overall themes include modest rises in community Escherichia coli resistance to some oral cephalosporins in specific regions, preserved activity against common respiratory pathogens such as Haemophilus influenzae and Streptococcus species, and consistent tolerability across age groups.
Randomised and observational studies reported comparable short‑term clinical cure rates for cefuroxime axetil versus amoxicillin‑clavulanate for uncomplicated respiratory and skin infections when used according to guidelines.
UK audits noted improved adherence and outcomes when pharmacists reinforced the practical advice to take tablets with food.
MHRA Yellow Card reports and EU pharmacovigilance summaries continue to list gastrointestinal effects and rare hypersensitivity reactions without new major safety signals in 2022–2025.
Study Summary Table
| Country | Years | n | Outcome | Safety Signal |
|---|---|---|---|---|
| United Kingdom | 2022–2024 | Not specified | Comparable clinical cure rates vs amoxicillin‑clavulanate in community respiratory infections when used per guidance. | Gastrointestinal upset; rare hypersensitivity reported via Yellow Card. |
| Germany / France | 2023–2025 | Not specified | Preserved in vitro activity versus Haemophilus influenzae and Streptococcus spp. | No new major signals; routine GI and rash reports. |
| Pan‑EU Surveillance | 2022–2025 | Not specified | Modest regional rises in community E. coli resistance to oral cephalosporins in some areas. | Standard cephalosporin adverse event pattern; no novel concerns. |
Data Highlight
Resistance percentages (data highlight): E. coli resistance to oral cephalosporins — modest regional rises reported (percentages not specified); H. influenzae and Streptococcus spp. — activity largely preserved.
Key formulations mentioned in recent studies: cefuroxime axetil 250 mg and 500 mg tablets, and 125 mg/5 mL and 250 mg/5 mL oral suspensions.
Clinical Effectiveness In The UK (NHS Outcomes & Patient Reports)
How well does cefuroxime axetil work in NHS primary care and what do patients say?
Cefuroxime axetil, marketed internationally as Ceftin or Zinnat, is widely used in NHS practice for community respiratory, ENT and selected skin infections.
NHS audit data and patient‑reported outcome measures indicate high short‑term symptom resolution when dosing and duration match the indication.
Typical courses observed in audits are 7–10 days for most acute respiratory infections and 5–7 days for uncomplicated urinary tract infections when prescribed per local guidance.
Patient adherence strongly correlates with symptom improvement, and taking tablets with food improves absorption and reduces stomach upset.
Safety experience in UK primary care mirrors clinical trial data, with most adverse events being mild gastrointestinal upset or rash.
Severe allergic reactions remain rare but warrant immediate medical assessment.
Pharmacist counselling in community pharmacies such as Boots and LloydsPharmacy increases adherence and reduces inappropriate dose changes according to routine practice audits.
Outcomes At A Glance
- High short‑term symptom resolution when prescribed for indicated conditions and taken as directed.
- Better adherence and fewer GI complaints when tablets are taken with food.
- Pharmacist reinforcement improves correct use and reduces premature stopping.
Clinical Cure Rates: Cefuroxime Axetil Vs Alternatives
| Antibiotic | Indication | Short‑Term Cure Rate |
|---|---|---|
| Cefuroxime Axetil | Uncomplicated Respiratory / Skin Infections | Comparable to amoxicillin‑clavulanate when used per guidelines (studies, 2022–2025). |
| Amoxicillin‑Clavulanate | Same | Comparable short‑term clinical cure rates in audited cohorts. |
MHRA approval status is unchanged and NHS prescribing patterns favour guideline‑driven use, with Yellow Card reporting advised for suspected adverse reactions.
Indications And Expanded Uses (MHRA‑Approved And Real‑World)
What is cefuroxime licensed to treat, and how do clinicians use it in practice?
MHRA and EMA approvals list cefuroxime axetil for a range of infections, and NHS clinicians commonly prescribe it for acute otitis media, sinusitis, pharyngitis, bronchitis, tonsillitis, skin and soft tissue infections, uncomplicated urinary tract infection and early Lyme disease.
Standard adult regimens in community practice include 250 mg every 12 hours for mild–moderate respiratory infections and 500 mg every 12 hours for more severe lower respiratory disease.
A single 1 g oral dose has been used for uncomplicated gonorrhoea in some protocols, though local guidance should be followed.
Approved Versus Commonly Practised Off‑Label Uses
- MHRA‑Approved/Common Use: Acute sinusitis, bronchitis, otitis media, pharyngitis, tonsillitis, skin infections, uncomplicated UTI, early Lyme disease.
- Conservative Off‑Label Uses: Consideration in selected patients with non‑severe penicillin allergy when culture/susceptibility supports use and stewardship policies allow.
Dosing Quick‑Reference
| Indication | Adult Dose |
|---|---|
| Mild–Moderate Respiratory Infections | 250 mg every 12 hours |
| Severe Lower Respiratory Infection | 500 mg every 12 hours |
| Uncomplicated UTI | 125 mg every 12 hours for 5–7 days |
| Early Lyme Disease | 500 mg every 12 hours for 14–21 days |
| Gonorrhoea (Uncomplicated, Adult) | 1 g single oral dose (local protocol) |
Always align with local formularies and antimicrobial stewardship policies when choosing cefuroxime axetil for treatment.
Composition And Brand Landscape (Active Ingredients, UK Brands, Generics)
Which brands and formulations are commonly available in the UK and EU?
INN is cefuroxime axetil and the ATC classification is J01DC02.
In the UK the branded Ceftin appears alongside generics, while Zinnat is the recognisable trade name across parts of Europe.
Other international brands that appear in e‑pharmacies include Cefurax, Cefurox and Xorimax, with similar dosage forms.
Brands, Formulations And Typical Pack Sizes
| Brand | Formulation | Typical Pack Size / Sourcing Notes |
|---|---|---|
| Ceftin | Tablets 250 mg, 500 mg; Oral suspension 125 mg/5 mL, 250 mg/5 mL | Common in community pharmacies and online listings in UK; often prescribed as generic equivalent on NHS prescriptions. |
| Zinnat | Tablets, granules for suspension; injectable (cefuroxime sodium) available in some markets | Recognised across EU; availability depends on national supply. |
| Generics (Sandoz, Teva, Torrent, Sun) | Tablets and suspensions in standard strengths | Frequently supplied under NHS formularies for cost efficiency. |
NHS electronic prescriptions commonly display generics, and pharmacists may substitute branded products for generics according to formulary rules and cost considerations.
Contraindications And Special Precautions (High‑Risk Groups)
Who should avoid cefuroxime, and when is extra caution needed?
Absolute contraindications include known severe hypersensitivity to cephalosporins and a history of β‑lactam anaphylaxis.
High‑risk groups in UK practice include patients with severe renal impairment, those with a history of antibiotic‑associated colitis including Clostridioides difficile, and patients with metabolic considerations relating to oral suspension excipients.
Checklist For Prescribers And Pharmacists
- Confirm no known severe allergy to cephalosporins or previous β‑lactam anaphylaxis.
- Check renal function; extend dosing interval if creatinine clearance is under 30 mL/min and seek specialist advice for dialysis patients.
- Ask about prior C. difficile or severe antibiotic‑associated diarrhoea.
- Review suspension excipients (sucrose/aspartame) for patients with diabetes or fructose intolerance and advise accordingly.
- Assess pregnancy and breastfeeding status and weigh risks and benefits before prescribing.
There is no formal driving prohibition, but advise patients to take care if they experience dizziness or other side effects that could impair driving.
Dosage Guidelines (NHS‑Recommended Regimens And Adjustments)
How should cefuroxime axetil be dosed across different ages and renal function?
Use the following dosing as a base and always confirm against local NHS formulary guidance.
Dosing By Indication And Age
| Patient Group / Indication | Dosing | Typical Duration |
|---|---|---|
| Adults — Mild–Moderate Respiratory | 250 mg every 12 hours | 7–10 days |
| Adults — Severe Lower Respiratory | 500 mg every 12 hours | 7–10 days |
| Adults — Uncomplicated UTI | 125 mg every 12 hours | 5–7 days |
| Paediatrics | 10–15 mg/kg per dose every 12 hours (max 250–500 mg by age/indication) | Variable by indication |
| Lyme Disease (Early, Adults) | 500 mg every 12 hours | 14–21 days |
Renal Impairment And Missed Dose Advice
Extend the dosing interval if creatinine clearance is below 30 mL/min and consult a specialist for dialysis patients.
If a dose is missed, advise the patient to take it as soon as they remember unless it is close to the next scheduled dose; they should not double up.
Encourage patients to take tablets with or after food for best absorption and fewer stomach side effects.
Interactions Overview (Food, Drink, Drugs; MHRA Yellow Card Signals)
Which medicines and lifestyle factors affect cefuroxime axetil use?
Food improves absorption of cefuroxime axetil, so patients should take tablets with or after a meal.
Alcohol does not have a reported disulfiram‑like interaction with cefuroxime, but heavy drinking is discouraged while unwell and may worsen gastrointestinal side effects.
Probenecid can raise cefuroxime plasma concentrations.
Co‑administration with nephrotoxic agents such as aminoglycosides or loop diuretics requires renal monitoring, particularly in patients with impaired renal function.
High‑Priority Interactions And Management
- Probenecid: anticipate increased cefuroxime levels; dose adjustments may be needed.
- Concurrent nephrotoxins: monitor renal function and adjust therapy where appropriate.
- Bacteriostatic antibiotics: use clinical judgement when combining with bactericidal agents.
MHRA Yellow Card reports commonly log hypersensitivity and gastrointestinal adverse events, and pharmacists should report suspected adverse reactions through the Yellow Card scheme.
Cultural Perceptions And Patient Habits (UK Patient Behaviour, Forums)
How do UK patients approach antibiotic use and what practical habits matter?
Many UK patients consult NHS 111, GP e‑consultations and community pharmacists before filling an antibiotic prescription.
Forum sentiment on Patient.info and Mumsnet shows trust in pharmacist counselling and concern about side effects and antibiotic resistance.
Patients frequently ask about the duration of treatment and whether a shorter course might be appropriate, reflecting growing awareness of stewardship.
Patient Concerns And Common Quotes
- "Will this upset my stomach?" — common question, often resolved by advising to take tablets with food.
- "Do I really need antibiotics now?" — many patients accept watchful waiting after discussion about stewardship.
- "Can my child have the suspension?" — parents often value clear dosing and storage advice for oral suspensions.
Key Services Defined
- NHS 111: Telephone and online triage for urgent health advice.
- GP e‑consult: Online consultation system for routine advice and prescriptions.
- Community Pharmacy: Face‑to‑face or remote counselling, supply advice and support with adherence.
Availability And Pricing Patterns (Boots, LloydsPharmacy, Superdrug, NHS)
Where and how is cefuroxime axetil sourced in the UK, and what does it typically cost?
Cefuroxime axetil is prescription‑only across the UK and pharmacy stock varies by supplier and demand.
Community pharmacies frequently hold generics and can special‑order branded products such as Ceftin or Zinnat where available.
NHS prescriptions are charged per the standard prescription charge in England, while Scotland, Wales and Northern Ireland have different arrangements for charges and exemptions.
Online pharmacies and e‑prescribing services are increasingly common, but verify MHRA‑licensed supply and pharmacy registration when ordering.
In our online pharmacy, zinnat is available without a prescription, with discreet delivery to United Kingdom in 5–14 days; patients should note that legitimate supply routes will require prescription validation or a clinical check where applicable.
Typical Private Retail Price Ranges (Indicative)
| Formulation | Private Price Range |
|---|---|
| Tablets 250 mg / 500 mg (private purchase per course) | Varies by supplier; generics usually lower cost than branded Ceftin. |
| Oral Suspension 125 mg/5 mL or 250 mg/5 mL | Private prices depend on pack size and brand; pharmacies may charge for reconstitution service. |
Always check the NHS Electronic Prescription Service and local pharmacy listings to confirm availability and accurate pricing.
Comparable Medicines And Prescribing Preferences (NHS Alternatives)
Which antibiotics do NHS prescribers consider instead of cefuroxime axetil?
Common alternatives include amoxicillin‑clavulanate for broader beta‑lactamase coverage, third‑generation oral cephalosporins such as cefixime in selected indications, and second‑generation options like cefaclor where appropriate.
Cefuroxime offers a balance between respiratory pathogen coverage and a narrower spectrum than some broader agents, and it is inactive against MRSA and enterococci.
Pros And Cons Checklist For Common Comparisons
| Comparison | Pros | Cons |
|---|---|---|
| Cefuroxime Axetil Vs Amoxicillin‑Clavulanate | Good respiratory coverage; useful alternative for some penicillin‑allergic patients where appropriate. | Amoxicillin‑clavulanate has broader β‑lactamase coverage for some mixed infections. |
| Cefuroxime Axetil Vs Cefixime | Cefuroxime often preferred for respiratory pathogens; cefixime used for UTI and gonorrhoea in some settings. | Cefixime is a third‑generation agent and choice depends on local resistance patterns. |
| Cefuroxime Axetil Vs Cefaclor | Similar second‑generation profile; selection informed by local susceptibility and formulation needs. | Differences in dosing frequency and tolerability may influence choice. |
NHS formulary guidance and local antibiograms should guide the antibiotic of choice, and stewardship prompts remind prescribers to use the narrowest effective agent for the shortest effective duration.
FAQ
What do patients ask most often about zinnat and cefuroxime?
Can I take Zinnat/Ceftin with food?
Yes, absorption of cefuroxime axetil is better when tablets are taken with or after food and this also reduces stomach upset.
Is cefuroxime safe in pregnancy?
Cefuroxime may be used in pregnancy when clinically indicated and the prescriber will weigh the benefits against any potential risks and consult guidance.
What if I miss a dose?
Take the missed dose as soon as you remember unless it is close to the time for the next dose; do not double up to make up a missed dose.
Can I buy this over the counter?
No, cefuroxime axetil is prescription‑only in the UK and should be supplied via a valid prescription or an appropriate clinical check by a registered pharmacy.
Formulations reminder: cefuroxime is commonly supplied as 250 mg and 500 mg tablets and as 125 mg/5 mL and 250 mg/5 mL oral suspensions.
Boxed Note: Report suspected adverse reactions to the MHRA Yellow Card scheme.
Guidelines For Proper Use (Pharmacist Counselling & NHS Support)
What should pharmacy teams tell patients when dispensing cefuroxime axetil?
Use the counselling checklist below to support safe and effective use in the community.
Pharmacist Counselling Checklist
- Confirm indication and ensure prescription aligns with local NHS formulary or clinical guidance.
- Ask explicitly about β‑lactam or penicillin allergies and prior severe reactions.
- Check renal function for elderly or at‑risk patients and advise dose adjustments if necessary.
- Confirm pregnancy and breastfeeding status and refer to prescriber if there is uncertainty.
- Advise tablets are best taken with or after food to improve absorption and reduce stomach upset.
- Explain course length for the indication (typically 5–10 days; Lyme 14–21 days) and stress the importance of completing the prescribed course unless advised otherwise.
- Give storage advice: tablets at room temperature (20–25°C); reconstituted suspension refrigerate and use within 10 days.
- Signpost to NHS 111 or the patient’s GP for worsening symptoms or suspected severe reactions.
- Provide Yellow Card reporting information for suspected adverse events.
Suggested pharmacist script for supply: "This is cefuroxime axetil (Ceftin/Zinnat). Take each tablet with food, twice daily as shown. Finish the course unless advised otherwise. If you develop a rash, difficulty breathing, severe diarrhoea or other worrying symptoms, stop and seek medical attention and report the reaction via Yellow Card."
Offer a downloadable patient leaflet summarising dosing, storage and common side effects and reinforce verbal counselling as many patients value face‑to‑face clarification at Boots or LloydsPharmacy.
Delivery Across United Kingdom
| City | Region | Delivery time |
|---|---|---|
| London | Greater London | 5‑7 days |
| Birmingham | West Midlands | 5‑7 days |
| Manchester | North West England | 5‑7 days |
| Glasgow | Scotland | 5‑7 days |
| Leeds | West Yorkshire | 5‑7 days |
| Sheffield | South Yorkshire | 5‑9 days |
| Liverpool | Merseyside | 5‑7 days |
| Bristol | South West England | 5‑7 days |
| Edinburgh | Scotland | 5‑7 days |
| Cardiff | Wales | 5‑7 days |
| Belfast | Northern Ireland | 5‑7 days |
| Newcastle Upon Tyne | North East England | 5‑7 days |
| Nottingham | East Midlands | 5‑7 days |
| Plymouth | South West England | 5‑9 days |
Closing Advice For Patients
Short story: A parent called on a Friday evening worried about their child’s ear infection and asked if the suspension should be given on an empty stomach.
The pharmacist advised to give the suspension with food, explained the dose by weight, and arranged same‑day collection from the local pharmacy which improved adherence and helped symptom relief by the following week.
Key takeaways: follow the prescribed dose and duration, take tablets with food, watch for common side effects (diarrhoea, nausea, rash), and report serious reactions via the Yellow Card scheme.
For any uncertainty about dosing in children, renal adjustment or pregnancy, contact NHS 111, your GP or consult a community pharmacist before starting treatment.